Home › NDC Lookup › RxCUI directory › RxCUI 2053504

50 ML fish oil (containing omega-3 acids) 100 MG/ML Injection [Omegaven] — RxCUI 2053504

RxNorm drug concept · Semantic branded drug
RxCUI 2053504 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2053504
Official name50 ML fish oil (containing omega-3 acids) 100 MG/ML Injection [Omegaven]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asOmegaven 10 % per 50 ML Injection; Omegaven 10 % in 50 ML Injection; 50 ML Omegaven 100 MG/ML Injection
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)3,018 prescriptions · 14 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How 50 ML fish oil (containing omega-3 acids) 100 MG... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 50 ML fish oil (containing omega-3 acids) 100 MG/ML Injection [Omegaven] RxCUI 2053504

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Fish oil (containing omega-3 acids) 2053495
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Omegaven 2053500
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Fish oil (containing omega-3 acids) Injection 2053498
    • Fish oil (containing omega-3 acids) Injectable Product 2053497
    • Fish oil (containing omega-3 acids) Injection [Omegaven] 2053502
    • Omegaven Injectable Product 2053503
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Fish oil (containing omega-3 acids) 100 MG/ML [Omegaven] SBDC · 2053501
  • Fish oil (containing omega-3 acids) Injection [Omegaven] SBDF · 2053502
  • Omegaven Injectable Product SBDG · 2053503
  • Omegaven BN · 2053500

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 2053504 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
63323-0205-00 10 VIAL, SINGLE-DOSE in 1 CARTON (63323-205-00) / 100 mL in... Omegaven Fresenius Kabi USA, LLC 2018-07-27
63323-0205-50 10 VIAL, SINGLE-DOSE in 1 CARTON (63323-205-50) / 50 mL in... Omegaven Fresenius Kabi USA, LLC 2018-07-27
Observed labelers: Fresenius Kabi USA, LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.